Piramal Pharma share price
You have to be logged in to add this to Watchlist.Piramal Pharma is trading -0.06% lower at Rs 249.75 as compared to its last closing price. Piramal Pharma has been trading in the price range of 257.25 & 247.25. Piramal Pharma has given 80.16% in this year & -3.68% in the last 5 days.
Piramal Pharma has TTM P/E ratio 672.14 as compared to the sector P/E of 33.29.There are 5 analysts who have initiated coverage on Piramal Pharma. There are 2 analysts who have given it a strong buy rating & 3 analysts have given it a buy rating. 0 analysts have given the stock a sell rating.
The company posted a net profit of 22.59 Crores in its last quarter.
Listed peers of Piramal Pharma include Indian Renewable Energy Development Agency (2.45%), Tata Technologies (0.25%), Piramal Pharma (-0.06%) etc.
Piramal Pharma has a 64.61% public holding.The Mutual Fund holding in Piramal Pharma was at 11.21% in 30 Sep 2024. The MF holding has increased from the last quarter. The FII holding in Piramal Pharma was at 13.73% in 30 Sep 2024. The FII holding has increased from the last quarter.
Piramal Pharma share price range
|
| ||||
|
| ||||
Piramal Pharma share Key Metrics
| Market Cap ( ₹ Cr.) | 33,015.47 | ||||||||||||||||||
|
|
Technical Trends
Long TermConsiders price movement over the last 6 months
Short TermConsiders price movement over the last 1-2 weeks
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Piramal Pharma Corporate actions
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
| 23-Oct-24 | Quarterly Results |
| 26-Jul-24 | Quarterly Results |
| 10-May-24 | Audited Results & Final Dividend |
| 30-Jan-24 | Quarterly Results |
| 27-Oct-23 | Quarterly Results |
| 03-Aug-23 | Quarterly Results |
| 24-May-23 | Audited Results |
| 08-Feb-23 | Quarterly Results & Rights issue |
| 08-Nov-22 | Quarterly Results |
| Meeting Date | Announcement On | Purpose |
| 26-Jul-24 | 11-Jun-24 | AGM |
| 31-Jul-23 | 16-Jun-23 | AGM |
| 22-Mar-23 | 20-Feb-23 | POM |
| Announcement On | Record Date | Ex-Dividend | Dividend Value |
| 10-May-24 | 12-Jul-24 | 12-Jul-24 | 0.11 |
| Announcement Date | Record Date | Ex-Rights Date | Ratio | FV | Description |
| 08-Feb-23 | 02-Aug-23 | 02-Aug-23 | 5:46 | 10 | Rights issue of equity shares of Rs. 10/- in the ratio of 5:46 @ premium of Rs. 71/-. |
FAQs about Piramal Pharma share price
Piramal Pharma is trading at 249.75 as on Mon Nov 25 2024 09:59:47. This is -0.06% lower as compared to its previous closing price of 249.90.
The market capitalization of Piramal Pharma is 33015.47 Cr as on Mon Nov 25 2024 09:59:47.
The average broker rating on Piramal Pharma is Strong Buy. The breakup of analyst rating is given below -
- 2 analysts have given a strong buy rating
- 3 analysts have given a buy rating
- 0 analysts have given a hold rating
- 0 analysts have given a sell rating
- 0 analysts have given a strong sell rating
The 52 wk high for Piramal Pharma is 307.85 whereas the 52 wk low is 114.45
Piramal Pharma can be analyzed on the following key metrics -
- TTM P/E: 672.14
- Sector P/E: 33.29
- Dividend Yield: 0.04%
- D/E ratio: 0.61
Piramal Pharma reported a net profit of 17.82 Cr in 2024.
Piramal Pharma Quick Links
Piramal Pharma Dividend Piramal Pharma Bonus Piramal Pharma News Piramal Pharma AGM Piramal Pharma Rights Piramal Pharma Splits Piramal Pharma Board Meetings Piramal Pharma Key Metrics Piramal Pharma Shareholdings Piramal Pharma Profit Loss Piramal Pharma Balance Sheet Piramal Pharma Cashflow Piramal Pharma Q1 Results Piramal Pharma Q2 Results Piramal Pharma Q3 Results Piramal Pharma Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks